Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p> Pharmaceutical companies, including OxyContin manufacturer, are being taken to task over what states are calling deceptive marketing of dangerous opioids.</p>

Lawsuits Accuse Pharma Companies of Deceiving Docs Over Opioid Risks

By Jill Drachenberg, Managing Editor, AHC Media

In a new effort to crack down on the opioid epidemic, state attorneys general across the United States are pursuing or considering pursuing legal action against pharmaceutical companies that produce opioid painkillers — in particular, OxyContin manufacturer Purdue Pharma.

Suffolk County, NY, filed a lawsuit against Purdue Pharma last week, alleging the company deceived physicians and patients about the dangers of abuse and addiction to OxyContin. The county included Johnson & Johnson and Endo International in its lawsuit. Chicago, Mississippi, New Hampshire, and two counties in California filed similar suits.

According to the Suffolk County lawsuit, the drug companies “sought to create a false perception of the safety and efficacy of opioids in the minds of medical professionals and members of the public that would encourage the use of opioids for longer periods of time and to treat a wider range of problems, including such common aches and pains as lower back pain, arthritis, and headaches.”

This is not the first time Purdue Pharma has faced legal action for its OxyContin marketing practices. In 2007, the company paid $20 million to 27 states over allegations it marketed the drug to physicians as less addictive as other painkillers. In a federal case, three Purdue executives pleaded guilty to misdemeanor charges, and the company was fined $600 million. The company also had to change its marketing practices — an issue that state attorneys general are now revisiting.

For more information on the opioid crisis, including new legislation and treatments for chronic pain conditions, check out AHC Media’s new premium, The Opioid Epidemic: New Policies, Treatments, and Non-opioid Alternatives.